Reported Tuberculosis in the United States, 2022

Return to Main Menu

Table 12. Tuberculosis Cases and Percentages Among U.S.-Born Persons1 by Drug Resistance and History of Previous TB Disease: United States, 1993–2022

See surveillance slides #42 and #43.

Five-year tuberculosis incidence rates by country of birth.
Year Total cases2 Isoniazid (INH)-resistant3 Multidrug resistant (MDR)4 Previous TB No previous TB
Total cases INH-resistant MDR Total cases INH-resistant MDR
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
2022 1,504 86 (5.7) 11 (0.7) 71 6 (8.5) 1 (1.4) 1,400 78 (5.6) 10 (0.7)
2021 1,565 88 (5.6) 9 (0.6) 39 0 (0.0) 0 (0.0) 1,507 85 (5.6) 9 (0.6)
2020 1,478 71 (4.8) 3 (0.2) 43 2 (4.7) 0 (0.0) 1,425 68 (4.8) 3 (0.2)
2019 1,897 124 (6.5) 13 (0.7) 59 4 (6.8) 1 (1.7) 1,826 119 (6.5) 12 (0.7)
2018 1,931 112 (5.8) 13 (0.7) 57 7 (12.3) 1 (1.8) 1,865 104 (5.6) 12 (0.6)
2017 1,906 106 (5.6) 19 (1.0) 58 3 (5.2) 2 (3.4) 1,845 103 (5.6) 17 (0.9)
2016 2,139 130 (6.1) 8 (0.4) 83 7 (8.4) 0 (0.0) 2,050 122 (6.0) 8 (0.4)
2015 2,298 158 (6.9) 13 (0.6) 101 7 (6.9) 3 (3.0) 2,192 150 (6.8) 10 (0.5)
2014 2,273 167 (7.3) 10 (0.4) 94 5 (5.3) 0 (0.0) 2,173 162 (7.5) 10 (0.5)
2013 2,373 140 (5.9) 9 (0.4) 98 8 (8.2) 2 (2.0) 2,261 129 (5.7) 7 (0.3)
2012 2,637 154 (5.8) 13 (0.5) 126 8 (6.3) 0 (0.0) 2,504 146 (5.8) 13 (0.5)
2011 2,831 182 (6.4) 18 (0.6) 136 10 (7.4) 1 (0.7) 2,681 171 (6.4) 17 (0.6)
2010 3,076 179 (5.8) 17 (0.6) 132 13 (9.8) 3 (2.3) 2,921 165 (5.6) 14 (0.5)
2009 3,228 201 (6.2) 13 (0.4) 116 6 (5.2) 1 (0.9) 3,086 192 (6.2) 12 (0.4)
2008 3,853 202 (5.2) 24 (0.6) 171 13 (7.6) 3 (1.8) 3,644 188 (5.2) 21 (0.6)
2007 4,075 181 (4.4) 22 (0.5) 206 14 (6.8) 3 (1.5) 3,846 163 (4.2) 18 (0.5)
2006 4,348 184 (4.2) 20 (0.5) 204 9 (4.4) 1 (0.5) 4,122 172 (4.2) 19 (0.5)
2005 4,662 210 (4.5) 23 (0.5) 240 18 (7.5) 2 (0.8) 4,394 188 (4.3) 20 (0.5)
2004 4,969 229 (4.6) 30 (0.6) 274 15 (5.5) 4 (1.5) 4,678 213 (4.6) 26 (0.6)
2003 5,142 231 (4.5) 26 (0.5) 253 16 (6.3) 2 (0.8) 4,846 213 (4.4) 23 (0.5)
2002 5,438 231 (4.2) 38 (0.7) 304 23 (7.6) 3 (1.0) 5,056 205 (4.1) 35 (0.7)
2001 5,960 271 (4.5) 41 (0.7) 325 28 (8.6) 7 (2.2) 5,565 240 (4.3) 34 (0.6)
2000 6,550 294 (4.5) 42 (0.6) 360 22 (6.1) 2 (0.6) 6,135 269 (4.4) 40 (0.7)
1999 7,476 319 (4.3) 46 (0.6) 382 25 (6.5) 6 (1.6) 7,007 284 (4.1) 39 (0.6)
1998 8,233 408 (5.0) 61 (0.7) 485 38 (7.8) 6 (1.2) 7,691 365 (4.7) 55 (0.7)
1997 9,183 472 (5.1) 89 (1.0) 455 35 (7.7) 12 (2.6) 8,696 435 (5.0) 76 (0.9)
1996 10,241 565 (5.5) 125 (1.2) 558 68 (12.2) 21 (3.8) 9,630 495 (5.1) 104 (1.1)
1995 10,992 637 (5.8) 199 (1.8) 592 77 (13.0) 28 (4.7) 10,332 554 (5.4) 169 (1.6)
1994 11,780 794 (6.7) 274 (2.3) 691 81 (11.7) 35 (5.1) 11,004 706 (6.4) 238 (2.2)
1993 12,530 873 (7.0) 331 (2.6) 668 83 (12.4) 30 (4.5) 11,802 788 (6.7) 301 (2.6)

1Persons born in the United States, certain U.S. territories, or elsewhere to at least one U.S. citizen parent are categorized as U.S.-born. All other persons are categorized as non-U.S.–born.
2Persons with isolates tested with at least isoniazid and rifiampin.
3Resistance to at least isoniazid.
4Resistance to at least isoniazid and rifampin.

Note:
Data for all years are updated through July 8, 2023.